Source evidence
Something wrong or missing? Send an update. Fixed within 24 hours.
D
AgomAb Therapeutics IPO
Company SEC-filed release confirms closing 12.5m ADSs at $16 each, $200m gross proceeds; pricing February 5 and listing February 6 are the same IPO.